A Phase 2 Study of ABSK021 in Patients With Advanced Pancreatic Cancer
NCT06111274 · Phase 2 · Recruiting
PHASEPhase 2
STATUSRecruiting
ENROLLMENT82
EST. COMPLETION2025-12-30
Conditions
Interventions
Study details
SPONSORAbbisko Therapeutics Co, Ltd
START DATE2023-10-17
Related company profiles
Primary source
Trial status and dates can change. Confirm enrollment and eligibility against the linked ClinicalTrials.gov record.
Evidence & limits
Source: Open the source record
- Record identifier
- NCT06111274
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Study information reported by the sponsor or investigator, including status, phase, enrollment, and recorded dates.
Limits. Registration or completion does not establish clinical success or approval. Sponsor-name associations can be ambiguous. Dates may be estimated; verify the live study record.
Connection basis. Company sponsor aliases and normalized lead-sponsor containment; the NCT identifier identifies the study.